Interestingly, a study published in 2014 showed that mesothelin601-615 was exclusively recognized by circulating CD4+ T cells from healthy individuals, but not by T cells from patients with pancreatic cancer [15]. This evidence concerns the gene CD4 and pancreatic neoplasm.